Zobrazeno 1 - 10
of 182
pro vyhledávání: '"Christopher L Edwards"'
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2008, Iss Issue 3, Pp 613-617 (2008)
Miriam Feliu1,2, Christopher L Edwards1,2,3, Shiv Sudhakar4, Camela McDougald1, Renee Raynor5, Stephanie Johnson6, Goldie Byrd7, Keith Whitfield8, Charles Jonassaint8, Heather Romero1, Lekisha Edwards1, Chante’ Wellington1, LaBarron K Hill9, James
Externí odkaz:
https://doaj.org/article/901f9f1343a94efd9d5940f8c0a0a1c5
Autor:
Christopher L Edwards, Renee Dunn Raynor, Miriam Feliu, Camela McDougald, Stephanie Johnson, et al
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2007, Iss Issue 6, Pp 705-709 (2007)
Christopher L Edwards1, Renee Dunn Raynor1, Miriam Feliu1, Camela McDougald1, Stephanie Johnson2, Donald Schmechel3, Mary Wood1, Gary G Bennett4, Patrick Saurona5, Melanie Bonner1, Chante’ Wellington1, Laura M DeCastro6, Elaine Whitworth6, Mary Abr
Externí odkaz:
https://doaj.org/article/9070e47afc6848a78a6aeae1f633781e
Autor:
Michaela Boggan, Christopher L. Edwards, Jordan Meek, Mary Wood, W. Jeff Bryson, John J. Sollers, Debra O. Parker, Camela S. Barker, Jessica Miller, Brianna Downey, Asha Lockett, Jazmin Rosales, Courtney Munroe, Jr., Noa Wax, Sharena Scott
Publikováno v:
Italian Journal of Medicine, Vol 18, Iss 3 (2024)
Sickle cell disease (SCD) is a collection of genetic lesions that manifest in the diminished effectiveness of hemoglobin. We collected and reviewed the recent and extant literature on SARS-CoV-2 (COVID-19) and SCD. We posit an answer to the question
Externí odkaz:
https://doaj.org/article/44f56346b723403894955d658125ef60
Autor:
Christopher L Edwards, Perrine Marie RUBY, Josie E Malinowski, Paul D. Bennett, Mark T Blagrove
Publikováno v:
Frontiers in Psychology, Vol 4 (2013)
This paper addresses claims that dreams can be a source of personal insight. Whereas there has been anecdotal backing for such claims, there is now tangential support from findings of the facilitative effect of sleep on cognitive insight, and of REM
Externí odkaz:
https://doaj.org/article/d2ba0ade07994b1f9433e01d81166230
Autor:
Christopher L. Edwards, Sharena Scott, Michaela Boggan, Jordan Meek, Kiera Alston, Aiden Pearson, Alexandria McDougald, McKenzie Broadnax, Mary Wood, Camela S. Barker, Jessica Miller, Elaine Whitworth, Osaffo James, John J. Sollers III, W. Jeff Bryson, Roland Thorpe, Goldie Byrd, Keith E. Whitfield, Shiv Sudhakar, Debra O. Parker, Jonathan Livingston, Nirmish Shah, Kenyon Railey
Publikováno v:
Journal of the National Medical Association. 115:26-37
Objective To delineate the etiology, symptomatology, and treatment of sickle cell intrahepatic cholestasis (SCIC). Sickle cell disease (SCD) is the most frequently inherited hematologic disease, and SCIC is one rare and often fatal complication and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2b07ba7b9b7e57a597dfa3044acccfc
https://doi.org/10.1016/j.jnma.2022.12.004
https://doi.org/10.1016/j.jnma.2022.12.004
Autor:
Grace Byfield, Takiyah D. Starks, Ronqeiya Luther, Christopher L. Edwards, Shawnta L. Lloyd, Allison Caban‐Holt, Larry Deon Adams, Jeffery M. Vance, Michael Cuccaro, Jonathan L. Haines, Christiane Reitz, Margaret A. Pericak‐Vance, Goldie S. Byrd
Publikováno v:
Alzheimer's & Dementia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6463774aa618682ee33472bac8812a43
https://doi.org/10.1002/alz.13106
https://doi.org/10.1002/alz.13106
Autor:
Kelli Kaufman, MS, Shao-Hua Chin, BS, Chanaka Kahathuduwa, MBBS, MPhil, Mary Wood, MA, Miriam Feliu, PsyD, LaBarron Hill, PhD, Camela Barker, MA, Rosellen Reif, MS, Abigail Keys, PsyD, Christopher L. Edwards, PhD, Martin Binks, PhD
Publikováno v:
Progress in Preventive Medicine, Vol 3, Iss 4, p e0019 (2018)
Pain, psychosocial issues and impaired activities of daily living (ADLs) are common in sickle cell disease (SCD). Improved longevity may be leading to increases in body mass index (BMI). We both describe an SCD clinic population and determine if BMI,
Externí odkaz:
https://doaj.org/article/7c22ec7dd20843de96f7bea7c2b7b4fc
Autor:
Olav W. Nielsen, Aldo P. Maggioni, Christopher L. Edwards, Marco Metra, Naoki Sato, Barry H. Greenberg, Faiez Zannad, Gad Cotter, Alexandre Mebazaa, Georg Ertl, Beth A. Davison, Alain Cohen-Solal, Ovidiu Chioncel, Stefanie Senger, John R. Teerlink
Publikováno v:
American Heart Journal
American Heart Journal, 2021, 240, pp.73-80. ⟨10.1016/j.ahj.2021.06.001⟩
Cotter, G, Davison, B A, Edwards, C, Senger, S, Teerlink, J R, Zannad, F, Nielsen, O W, Metra, M, Mebazaa, A, Chioncel, O, Greenberg, B H, Maggioni, A P, Ertl, G, Sato, N & Cohen-Solal, A 2021, ' Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials ', American Heart Journal, vol. 240, pp. 73-80 . https://doi.org/10.1016/j.ahj.2021.06.001
American Heart Journal, 2021, 240, pp.73-80. ⟨10.1016/j.ahj.2021.06.001⟩
Cotter, G, Davison, B A, Edwards, C, Senger, S, Teerlink, J R, Zannad, F, Nielsen, O W, Metra, M, Mebazaa, A, Chioncel, O, Greenberg, B H, Maggioni, A P, Ertl, G, Sato, N & Cohen-Solal, A 2021, ' Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials ', American Heart Journal, vol. 240, pp. 73-80 . https://doi.org/10.1016/j.ahj.2021.06.001
International audience; Background In international trials, glucagon-like protein-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2Is) were effective in improving cardiovascular (CV) outcomes. Methods We assessed the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40eaf71fb56ee34541e8ad33fb460d0a
https://doi.org/10.1016/j.ahj.2021.06.001
https://doi.org/10.1016/j.ahj.2021.06.001
Autor:
B. Davison, Gary G. Koch, Howard C. Dittrich, Gad Cotter, Naim Alkhouri, Stephen A. Harrison, Christopher L. Edwards, Rohit Loomba
Publikováno v:
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
JGH Open, Vol 5, Iss 7, Pp 740-749 (2021)
JGH Open, Vol 5, Iss 7, Pp 740-749 (2021)
Background and Aim Liver histology changes are the current gold standard for evaluating non‐alcoholic steatohepatitis (NASH), but are limited by their invasiveness and variability for sampling and interpretation. We evaluated noninvasive biomarkers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5d4d141c6297d66d23cc146e2c40aba
https://doi.org/10.1002/jgh3.12575
https://doi.org/10.1002/jgh3.12575
Autor:
Gary G. Koch, Howard C. Dittrich, Gad Cotter, Beth A. Davison, Jerry R. Colca, Arun J. Sanyal, Julie Iwashita, Christopher L. Edwards, Naim Alkhouri, Stephen A. Harrison
Publikováno v:
Journal of Hepatology. 73:1322-1332
Background & Aims Liver biopsies are a critical component of pivotal studies in non-alcoholic steatohepatitis (NASH), constituting inclusion criteria, risk stratification factors and endpoints. We evaluated the reliability of NASH Clinical Research N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b867a39ace31820225ef357dede0cf4
https://doi.org/10.1016/j.jhep.2020.06.025
https://doi.org/10.1016/j.jhep.2020.06.025